Varying Dose of Atropine in Slowing Myopia Progression in Children Over Different Follow-Up Periods by Meta-Analysis

To evaluate the efficacy and safety of atropine for slowing myopia progression and to investigate whether the treatment effect remains constant with continuing treatment. Studies were retrieved from MEDLINE, EMBASE, and the Cochrane Library from their inception to May 2021, and the language was limi...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in medicine 2022-01, Vol.8, p.756398-756398
Main Authors: Gan, Jiahe, Li, Shi-Ming, Wu, Shanshan, Cao, Kai, Ma, Dandan, He, Xi, Hua, Ziyu, Kang, Meng-Tian, Wei, Shifei, Bai, Weiling, Wang, Ningli
Format: Article
Language:English
Subjects:
atropine
dose
efficacy & safety
follow-up
Medicine
myopia
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To evaluate the efficacy and safety of atropine for slowing myopia progression and to investigate whether the treatment effect remains constant with continuing treatment. Studies were retrieved from MEDLINE, EMBASE, and the Cochrane Library from their inception to May 2021, and the language was limited to English. Randomized controlled trials (RCTs) and cohort studies involving atropine in at least one intervention and placebo/non-atropine treatment in another as the control were included and subgroup analysis based on low dose (0.01%), moderate dose (0.01%-
ISSN:2296-858X
2296-858X
DOI:10.3389/fmed.2021.756398